Feeds › Merger clearances (HSR)
Merger clearances (HSR)
Mergers and acquisitions the FTC and Justice Department cleared early under the Hart-Scott-Rodino Act, with the public companies among them. Granted requests only.
About this data
- What it is
- Companies planning a merger or acquisition above a size threshold must tell the FTC and the Justice Department first and wait 30 days before closing (the Hart-Scott-Rodino Act). The parties can ask for that wait to end early, and when the agencies agree, the FTC publishes an early termination notice. This feed lists those notices: the buyer, the target, the entities being acquired and the day early termination was granted. We match each name to a public company when it lines up.
- Who files it
- The FTC, which publishes a notice once it and the Department of Justice have granted the request.
- How current
- We check the FTC's list every day. A notice is published when early termination is granted, which is before the deal closes.
- Terms
- Hart-Scott-RodinoThe Hart-Scott-Rodino Act requires companies planning a merger or acquisition above a size threshold to tell the FTC and the Justice Department first and wait 30 days before closing, so the agencies can look for competition problems.Early terminationThe parties can ask for that waiting period to end sooner. When the agencies agree, the FTC publishes an early termination notice. It means the deal was cleared to close early, not that the agencies endorse it.Possible matchWe match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match.
- Worth knowing
- This is a partial list of deals, not every merger. Only requests that were granted appear: deals that waited out the full 30 days, deals whose request was refused and deals that were never reportable are not listed. The FTC granted no early terminations from February 2021 until the new HSR form took effect in February 2025, so there is nothing between those dates. A notice does not mean the agencies endorse a deal, and it does not say whether the deal closed. Most buyers and targets are private companies, funds or people. We match names to public companies automatically; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly.
This comes from the FTC's list of early-termination notices.
Source and freshness · Information, not investment advice (disclaimer).
Early terminations granted per month, last 24 months
Only granted requests are listed, not every deal. The FTC granted none from February 2021 until the new HSR form took effect in February 2025.
Latest early terminations granted
Showing: ticker ABT
Only early terminations that were granted are listed, not every deal, and none were granted between February 2021 and February 2025.
| Granted | BuyerThe "acquiring person" in the filing: the ultimate parent entity of the buyer, which can be a company, a fund or a person. We match each name to a public company automatically. A name that matches closely is shown as a company; a looser match is marked "possible match" because a similar name, a subsidiary or a differently spelled name can be matched wrongly. Most parties are private companies and funds and have no match. | TargetThe "acquired person": the ultimate parent entity of the target. The entities actually being acquired are listed under it. | Transaction | Source |
|---|---|---|---|---|
| Sep 28, 2017 | Abbott Laboratories | Alere Inc. | 20160815 | FTC ↗ |
| Dec 27, 2016 | Abbott Laboratories | St. Jude Medical, Inc | 20161298 | FTC ↗ |
| Feb 4, 2015 | Zoetis, Inc. | Abbott Laboratories | 20150348 | FTC ↗ |
| Dec 9, 2014 | Abbott Laboratories | Topera, Inc. | 20150235 | FTC ↗ |
| Aug 14, 2013 | Abbott Laboratories | IDEV Technologies, Inc. | 20131117 | FTC ↗ |
| Aug 2, 2013 | Abbott Laboratories | OptiMedica Corporation | 20131119 | FTC ↗ |
| Jun 11, 2012 | Abbott Laboratories | Action Pharma A/S | 20120850 | FTC ↗ |
| Dec 8, 2009 | Abbott Laboratories | PanGenetics 110 B.V. | 20100193 | FTC ↗ |
| Nov 19, 2009 | Abbott Laboratories | Solvay SA Sodufa BV; Solvay Pharmaceuticals Marketing & Licensing AG | 20100048 | FTC ↗ |
| Oct 28, 2009 | Abbott Laboratories | Evalve, Inc. | 20090792 | FTC ↗ |
| Oct 15, 2009 | Abbott Laboratories, Inc. | Visiogen Inc. | 20090763 | FTC ↗ |
| Oct 9, 2008 | Zimmer Holdings, Inc. | Abbott Laboratories Abbott Spine S.A.; Abbott Spine, Inc. | 20081789 | FTC ↗ |
| Feb 23, 2007 | General Electric Company | Abbott Laboratories | 20070733 | FTC ↗ |
| Dec 15, 2006 | Abbott Laboratories | Enanta Pharmaceuticals, Inc. | 20070386 | FTC ↗ |
| Dec 4, 2006 | Abbott Laboratories | Kos Pharmaceuticals, Inc. | 20070362 | FTC ↗ |
| Jul 17, 2006 | AstraZeneca plc | Abbott Laboratories Abbott Pharmaceuticals PR Ltd. | 20061389 | FTC ↗ |
| Apr 19, 2006 | Abbott Laboratories | Boston Scientific Corporation | 20060799 | FTC ↗ |
| Dec 12, 2005 | Novartis AG | Abbott Laboratories TAP Pharmaceutical Products Inc. | 20060250 | FTC ↗ |
| Apr 15, 2005 | Abbott Laboratories | MedNova Limited | 20050819 | FTC ↗ |
| Oct 18, 2004 | Abbott Laboratories | North Castle Partners II, L.P. Natural Supplement Association, Inc. | 20050027 | FTC ↗ |
| Nov 28, 2003 | Reliant Pharmaceuticals, LLC | Abbott Laboratories | 20040119 | FTC ↗ |
| Sep 29, 2003 | Mayne Group Limited | Abbott Laboratories | 20030951 | FTC ↗ |
| Aug 18, 2003 | Abbott Laboratories | Mr. Christopher P. Baker ZonePerfect Nutrition Company | 20030832 | FTC ↗ |
| Jun 13, 2003 | Abbott Laboratories | Spinal Concepts, Inc. | 20030683 | FTC ↗ |
| Dec 6, 2002 | Bonita Bay Holdings, Inc. | Abbott Laboratories | 20030170 | FTC ↗ |
| Apr 23, 2002 | Abbott Laboratories | Biocompatibles International plc Biocompatibles Cardiovascular Inc. | 20020626 | FTC ↗ |
| Dec 5, 2000 | Cephalon, Inc. | Abbott Laboratories | 20010552 | FTC ↗ |
| Feb 17, 2000 | Abbott Laboratories | Elan Corporation, plc Elan Pharmaceuticals, Inc. | 20001799 | FTC ↗ |
| Dec 27, 1999 | Sumitomo Chemical Company, Limited | Abbott Laboratories Chemical & Agricultural Products Division | 20000915 | FTC ↗ |
| Nov 18, 1999 | Abbott Laboratories | Glaxo Wellcome plc Glaxo Wellcome Inc., Glaxo Group Limited | 20000096 | FTC ↗ |
| Aug 16, 1999 | Abbott Laboratories | Perclose, Inc. | 19993836 | FTC ↗ |
| Jul 15, 1999 | Abbott Laboratories | Triangle Pharmaceuticals, Inc. | 19993515 | FTC ↗ |
32 items, most recent first (up to 50). Each row links to the FTC page that lists the notices; the transaction number identifies it there. Updated Nov 15, 2026, 5:19 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances